Status:
COMPLETED
Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary Care
Lead Sponsor:
New York State Psychiatric Institute
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Heroin Dependence
Opioid-Related Disorders
Eligibility:
All Genders
18-65 years
Brief Summary
The purpose of this treatment research study is to assess the effectiveness of buprenorphine maintenance treatment for opioid dependence delivered in a primary care clinic setting. This study will det...
Detailed Description
Buprenorphine maintenance treatment of opioid dependence in primary care may expand treatment access. Buprenorphine is a partial mu-opioid agonist approved for treatment of opioid dependence (dependen...
Eligibility Criteria
Inclusion
- DSM-IV criteria for current opioid dependence
- Must be seeking treatment
- Must describe opioid medication or heroin as primary drug of abuse
- Must be financially able to receive treatment at the primary care clinic site and to receive medication (e.g., Medicaid)
- Able to give informed consent and comply with study procedures
Exclusion
- Axis I psychiatric disorder(s) as defined by DSM-IV-TR that are unstable or would be disrupted by study participation
- Individuals at significant risk for suicide based on current mental state
- DSM-IV dependence with physiologic dependence other than opioid and nicotine
- Women must not be pregnant or lactating, and must agree to use a proven effective method of contraception and not become pregnant during the study
- Unstable physical disorder that might make participation hazardous
- Known allergy, sensitivity or adverse reaction to buprenorphine
- Current buprenorphine maintenance
- Inability to read or understand the self-report assessment forms unaided
Key Trial Info
Start Date :
June 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2012
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00471042
Start Date
June 1 2006
End Date
August 1 2012
Last Update
April 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University/New York State Psychiatric Institute
New York, New York, United States, 10032